Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDK1 pseudogene 2 (PDK1P2) is a non-coding pseudogene related to Pyruvate dehydrogenase kinase 1 (PDK1). Pseudogenes are generally non-functional copies of ancestral genes that may be transcribed as RNA but do not code for functional proteins due to mutations, frameshifts, or premature stop codons[5]. PDK1P2 has sequence similarity to the functional PDK1 gene but lacks protein-coding capacity. Some recent research has identified PDK1P2 (also referred to as lncRNA-PDPK2P) as a long non-coding RNA capable of acting as a competitive endogenous RNA, thereby indirectly regulating PDK1 levels and, subsequently, cellular processes such as proliferation and apoptosis in cancers like hepatocellular carcinoma[1]. However, PDK1P2 itself is not a therapeutic drug target, receptor, enzyme, or signaling protein, but may have an ancillary regulatory function on its functional counterpart.[1][5] If your inquiry pertains to druggable or therapeutically relevant protein targets, the correct entry would be "Pyruvate dehydrogenase kinase 1 (PDK1)" rather than the pseudogene PDK1P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pyruvate dehydrogenase kinase 1 pseudogene 2 (PDK1P2).